Influencing tumor-associated macrophages in malignant melanoma with monoclonal antibodies
The application of monoclonal antibodies (mAbs) for the treatment of melanoma has significantly improved the clinical management of this malignancy over the last decade. Currently approved mAbs for melanoma enhance T cell effector immune responses by blocking immune checkpoint molecules PD-L1/PD-1 a...
Main Authors: | Rebecca Adams, Gabriel Osborn, Bipashna Mukhia, Roman Laddach, Zena Willsmore, Alicia Chenoweth, Jenny L C Geh, Alastair D MacKenzie Ross, Ciaran Healy, Linda Barber, Sophia Tsoka, Victoria Sanz-Moreno, Katie E Lacy, Sophia N Karagiannis |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2022-12-01
|
Series: | OncoImmunology |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/2162402X.2022.2127284 |
Similar Items
-
Monoclonal antibodies : the second generation /
by: 186276 Zola, Heddy
Published: (1995) -
Monoclonal antibodies /
by: Peter, J. H., et al.
Published: (1992) -
Large-scale production of monoclonal antibodies in suspension culture /
by: 271860 Backer, M. P., et al. -
Monoclonal antibodies : principles and practice : production and application of monoclonal antibodies in cell biology, biochemistry and immunology /
by: 250151 Goding, James W.
Published: (1996) -
Monoclonal antibodies in immunoscintigraphy /
by: Chatal, Jean-Francois
Published: (1989)